クイック注文

AKT2/PKB beta  タンパク質

All AKT2 Reagents

製品の説明:   
発現宿主: Baculovirus-Insect Cells  
  • Slide 1
10764-H20B-50
10764-H20B-20
50 µg 
20 µg 
Add to Cart

Browse AKT2/PKB beta Products by

AKT2/PKB beta 関連経路

AKT2/PKB beta サマリー & タンパク質情報

AKT2/PKB beta 背景

触媒活性: ATP + a protein = ADP + a phosphoprotein.
酵素調節: Two specific sites, one in the kinase domain (Thr-309) and the other in the C-terminal regulatory region (Ser- 474), need to be phosphorylated for its full activation. Aminofurazans are potent AKT2 inhibitors.
サブユニット構造: Interacts (via PH domain) with MTCP1, TCL1A AND TCL1B. Interacts with CLK2, PBH2 and TRAF6.
ドメイン: Binding of the PH domain to phosphatidylinositol 3,4,5- trisphosphate (PI(3,4,5)P3) following phosphatidylinositol 3- kinase alpha (PIK3CA) activity results in its targeting to the plasma membrane.
細胞内位置: Cytoplasm. Nucleus. Cell membrane; Peripheral membrane protein. Note=Localizes within both nucleus and cytoplasm of proliferative primary myoblasts and mostly within the nucleus of differentiated primary myoblasts. By virtue of the N-terminal PH domain, is recruited to sites of the plasma membrane containing increased PI(3,4,5)P3 or PI(3,4)P2.
組織特異性: Expressed in all cell types so far analyzed.
翻訳後: Phosphorylation on Thr-309 and Ser-474 is required for full activity.
Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT2 ubiquitination. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome.
O-GlcNAcylation at Thr-306 and Thr-313 inhibits activating phosphorylation at Thr-309 via disrupting the interaction between AKT and PDK1 (By similarity).
疾患関連性: Note=Defects in AKT2 are a cause of susceptibility to breast cancer (BC). AKT2 promotes metastasis of tumor cells without affecting the latency of tumor development. With AKT3, plays also a pivotal role in the biology of glioblastoma.
Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. Note=The disease is caused by mutations affecting the gene represented in this entry.
Hypoinsulinemic hypoglycemia with hemihypertrophy (HIHGHH) [MIM:240900]: A disorder characterized by hypoglycemia, low insulin levels, low serum levels of ketone bodies and branched-chain amino acids, left-sided hemihypertrophy, neonatal macrosomia, reduced consciousness and hypoglycemic seizures. Note=The disease is caused by mutations affecting the gene represented in this entry.
シーケンスの類似性: Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily.
Contains 1 AGC-kinase C-terminal domain.
Contains 1 PH domain.
Contains 1 protein kinase domain.
General information above from UniProt

AKT2/PKB beta 代替名

PKBB,PRKBB,HIHGHH,PKBBETA,RAC-BETA, [homo-sapiens]
HIHGHH ,PKBB,PKBBETA,PRKBB,RAC-BETA, [Human]
2410016A19Rik,AW554154,PKBbeta, [mouse]
PKB,PKBbeta,AW554154,2410016A19Rik, [mus-musculus]

AKT2/PKB beta 関連研究

注意:すべての製品は、"研究目的のみに使用するものであり、診断または治療目的に使用するものではありません"